2010-04-13 16:37:58 UTC

QOL in Cirrhosis Is Related to Treatable Factors

April 13, 2010

Improvement of prognosis and availability of diverse therapeutic options for complications of advanced liver disease highlight the importance of health-related quality of life in cirrhosis. In a study published in the European Journal of Gastroenterology & Hepatology, doctors concluded that several clinical variables, potentially treatable, may alter particular aspects of health-related quality of life. Correction of ascites, hypo-albuminemia, minimal hepatic encephalopathy and anemia may cause a positive impact on health-related quality of life of patients with cirrhosis. 

 

More on Cirrhosis

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.

Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis

Oct. 11, 2017

Statin use is probably associated with lower risk of hepatic decompensation and mortality, and might reduce portal hypertension, in patients with CLDs.

Cirrhosis Presenting as Cutaneous Calciphylaxis

Oct. 11, 2017

A 73-year-old woman with a history of hypertension presented with a 3-month history of a painful, non-healing right calf ulcer and 2–3 weeks of painful, dusky purple patches on the right thigh.